Navigation Links
Fibromyalgia Is Not All In Your Head, New Research Confirms
Date:6/20/2013

with Albany Medical Center neurologists Dr. Charles E. Argoff and Dr. James Wymer and Dr. James Storey of Upstate Clinical Research Associates (Albany, NY), the study was funded by Forest Laboratories and Eli Lilly.  Both pharmaceutical companies have developed FDA-approved medications with similar functions (Serotonin/Norepinephrine Reuptake Inhibitors, SNRI) that provide at least some degree of relief for many fibromyalgia patients.

"Knowing how these drugs were supposed to work on molecules in the brain," Dr. Albrecht added, "we had evidence that similar molecules were involved in the function of nerve endings on the blood vessels. Therefore, we hypothesized that fibromyalgia might involve a pathology in that location." As the results demonstrate, they were correct.

A Thermostat for the Skin

Importantly, the excessive nerve fibers were concentrated around tiny muscular valves, called arteriole-venule (AV) shunts (see diagram).  In humans, these shunts are found in the palms of our hands and soles of our feet and work like the radiator in a car. In warm conditions, the shunts close, which forces blood into the capillaries at the skin surface to radiate heat from the body. Under cold conditions, the shunts open allowing blood to bypass the capillaries to conserve heat, which is why our hands get cold.

According to Dr. Albrecht, "the excess sensory innervation may explain why fibromyalgia patients typically have especially tender and painful hands."

Noting that blood flow to the hands is normally known to be diverted to muscles during exercise, Dr. Rice proposes that "That mismanaged blood flow due to malfunctioning shunts could also interfere with blood flow to the muscles throughout the body. This could be the source of wide spread muscular pain, achiness and fatigue which are thought to be due to a build
'/>"/>

SOURCE Intidyn
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Synthetic Biologics Reports that Flupirtine Sublicensee, Meda AB, to Initiate Phase II Fibromyalgia Clinical Trial in U.S.
2. Soterix Medical Inc. reports positive results from High-Definition tDCS Fibromyalgia Trial at Harvard Medical School
3. WAISMANN METHOD® Medical Director Voices Support for Fibromyalgia Awareness Day
4. With Busy Summer Forecast Ahead, More Hotels Are Raising Hygiene Standards, Says UMF Corporation
5. BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research
6. New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research
7. Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics
8. Southern Research Institute Names Arthur J. Tipton, Ph.D. President and CEO
9. University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work
10. Pancreatic Cancer Advocates Call on Congress to Protect Medical Research Funding From Sequestration Cuts
11. Ongoing Clinical Trials Reveal Groundbreaking Results - Research Report on Alexion, BioMarin, Onyx, Questcor, and ImmunoGen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... NOTTINGHAM, United Kingdom , Oct. 30, 2014 /PRNewswire/ ... Inc., (Nasdaq: CBRX ) and ... assist drug developers with improved efficiency during clinical development ... San Diego next week. This ... enabling technologies platform, which it launched earlier this month. ...
(Date:10/30/2014)... , Oct. 30, 2014   BioLife Solutions ... developer, manufacturer and marketer of proprietary clinical grade ... and precision thermal shipping products for cells ... quarter 2014 financial results will be released on Thursday, ... a conference call and live webcast at 1:30 p.m. ...
(Date:10/30/2014)...   Auxilium Pharmaceuticals , Inc. (NASDAQ: ... company, today announced financial results for the third ... important corporate, commercial, regulatory and clinical development updates ... very pleased with the continued momentum and strong ... portfolio this quarter, especially the XIAFLEX franchise, which ...
Breaking Medicine Technology:Molecular Profiles To Launch US Strategic Alliance At AAPS 2Molecular Profiles To Launch US Strategic Alliance At AAPS 3BioLife Solutions to Report Financial Results for Third Quarter 2014 and Provide Business Update on November 6, 2014 2Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 2Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 3Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 4Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 5Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 6Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 7Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 8Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 9Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 10Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 11Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 12Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 13Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 14Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 15Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 16Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 17Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 18Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 19Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 20Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 21Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 22
... and Progressive Form of Inflammatory Spinal Arthritis Receiving Monthly Golimumab ... ... BOSTON, Nov. 7 More than half of patients receiving,monthly ... experienced significant and sustained improvements in the signs and,symptoms of active ...
... of Trial Volunteers Must Remain Paramount Concern, SEATTLE, ... the following statement today from Executive,Director Mitchell Warren in ... AIDS vaccine study by Merck & Co., the US ... HIV Vaccine Trials Network,(HVTN) at a public forum at ...
Cached Medicine Technology:New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 2New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 3New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 4New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 5New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 6New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 7AIDS Vaccine Advocacy Coalition Calls for AIDS Vaccine Field to Work Together to Analyze STEP Study Data and Determine Best Course to Move Forward 2AIDS Vaccine Advocacy Coalition Calls for AIDS Vaccine Field to Work Together to Analyze STEP Study Data and Determine Best Course to Move Forward 3
(Date:10/30/2014)... WHAT: , A mathematical model developed by NIH grantees ... daily to prevent HIV infection via vaginal sex, whereas ... HIV infection via anal sex. This finding helps explain ... or PrEP, in women failed to show efficacy. Participants ... trials of Truvada and tenofovir (another antiretroviral) for HIV ...
(Date:10/30/2014)... San Diego, Calif. (PRWEB) October 30, 2014 ... no longer mutually exclusive concepts in the medical-grade ... focusing on the development of uniquely potent topical ... Skin Health System ( http://www.RefinitySkinScience.com ) with patented ... highest available glycolic acid concentrations (50% and 70%) ...
(Date:10/30/2014)... By Steven Reinberg ... -- Giving hormone therapy to men with prostate cancer who ... dying from a heart-related cause, a new study suggests. , , ... It,s used in prostate cancer to reduce levels of male ... the study. And, in the current research, this hormone therapy ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Horse ... therapeutic horseback riding to special needs individuals in the ... on Saturday, November 15 from 10-2:00 p.m. at Bailey's ... is open to the public and is designed to ... , Admission to the HSS Round-Up is free. Ticket ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 The annual ... (NAMS) came to a close on Saturday, October 18th, ... the Society’s inception in 1989. NAMS is North America’s ... quality of life of all women during midlife and ... With over 2,000 physicians and thought leaders from fields ...
Breaking Medicine News(10 mins):Health News:Model by NIH grantees explains why HIV prevention dosing differs by sex 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 3Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 4Health News:Hormone Therapy May Up Heart-Related Deaths in Some Prostate Cancer Patients 2Health News:Hormone Therapy May Up Heart-Related Deaths in Some Prostate Cancer Patients 3Health News:Horse Sense & Sensitivity, Jacksonville Non-profit, To Hold 2nd Annual Round-Up 2Health News:Highlights from The North American Menopause Society 25th Annual Meeting 2Health News:Highlights from The North American Menopause Society 25th Annual Meeting 3
... at Rice University have discovered that intense pressure -- ... half-mile beneath the ocean,s surface -- stimulates cartilage cells ... properties of natural cartilage. The new method, which requires ... of arthritis sufferers. , "This tissue-engineering method holds promise ...
... honoured with a Commendation in this year,s Premier,s Award ... Fellow and was previously a PhD student in WEHI,s ... Priscilla with the Commendation at a ceremony at Government ... on two key aspects of cancer biology. First, identifying ...
... once-a-week participation was associated with improved results , , WEDNESDAY, ... Anonymous offer benefits to adolescents, even if they eventually ... teens enrolled at two treatment centers in California. ... from four to six weeks at the centers, which ...
... societal, and health carerelated issues contribute to disparities in ... to two articles appearing in the July 2008 issue ... The articles indicate that immediate and substantial efforts on ... health care for affected Americans. Such concerted efforts can ...
... Provide Alaska Rural Telecommunication Services for Next ... ... GNCMA ),announced today that it successfully transitioned all of its rural,telecommunication ... Internet, distance education and,telehealth services throughout rural Alaska for the next 14 ...
... from Thomson Reuters to Analyze Promising Drugs Changing Clinical Phase, ... Generics ... ... leading source of intelligent information for businesses and,professionals, has announced the ...
Cached Medicine News:Health News:Cartilage regeneration '20,000 Leagues Under the Sea' 2Health News:Cartilage regeneration '20,000 Leagues Under the Sea' 3Health News:Insights into cancer earn Premier's Award Commendation 2Health News:Alcohol, Drug Counseling Benefits Teens, Too 2Health News:Racial disparities in the outcomes of patients with chronic kidney disease abound 2Health News:Racial disparities in the outcomes of patients with chronic kidney disease abound 3Health News:GCI Successfully Transitions All Traffic to Galaxy 18 Satellite 2Health News:The Scientific Business of Thomson Reuters Publishes Pharma Matters - a Series of Reviews Covering Various Aspects of the Pharmaceutical Pipeline 2Health News:The Scientific Business of Thomson Reuters Publishes Pharma Matters - a Series of Reviews Covering Various Aspects of the Pharmaceutical Pipeline 3
... rotary retracting, self-lubricating design and has a heavy ... construction makes it accurate and incredibly reliable. ,The ... lateral motion is controlled and allows no slop ... lesser designs which can result in 'chatter' and ...
... The new SureCut M3500 Radial Microtome has ... is marvelous, and a range of functions and ... users. Based on years of experience and ... innovative design the SureCut M3500 Microtome will be ...
This is an economical (portable) microtome designed for fast and accurate sectioning. The specimen rise is automatic and accurate with each handle movement. Section thickness from 5 to 40 microns. ...
Honing compound for knife sharpening, 6 grams net...
Medicine Products: